Physician

Abbe F Rosenbaum, M.D.

According to 2025 Medicare claims, Abbe Rosenbaum, M.D. (NPI: 1356304554) practices cardiology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE ASSOCIATES PA (NPI: 1831123520; TIN: 65-0511644) and primary practice location at 33143-4829. Rosenbaum is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Rosenbaum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 846 traditional Medicare patients, billed 7,011 HCPCS/CPT codes, and received $509,501 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,295 prescription claims across 743 beneficiaries totaling $665,915 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 23 claims. Open Payments data shows 11 records totaling $353. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $152,285 to $509,501. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $196,145 to $665,915. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $790 to $6,866.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	587	4,406	$152,285
2016	613	4,631	$165,780
2017	647	4,155	$174,458
2018	710	5,177	$195,629
2019	746	5,188	$225,186
2020	668	7,674	$294,352
2021	755	8,322	$408,636
2022	787	8,309	$414,229
2023	733	7,318	$431,799
2024	846	7,011	$509,501

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	307	3,302	$196,145
2016	364	4,291	$260,570
2017	421	4,710	$302,499
2018	488	4,765	$308,431
2019	528	4,941	$440,037
2020	568	5,391	$490,648
2021	613	5,700	$536,342
2022	654	6,064	$626,843
2023	718	6,336	$670,659
2024	743	6,295	$665,915

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	23	$1,268
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	386	386	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	452	597	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	284	414	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	277	336	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	571	799	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	170	11,357	$219,761
Entresto	Sacubitril/Valsartan	60	2,565	$57,033
Xarelto	Rivaroxaban	39	3,010	$54,923
Repatha Sureclick	Evolocumab	56	2,444	$48,379
Mounjaro	Tirzepatide	34	1,124	$39,188

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$353	HEARTFLOW, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abbe F. Rosenbaum, M.D.?

Tedicare shows public-source Medicare data for Abbe F. Rosenbaum, M.D. (NPI 1356304554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abbe F. Rosenbaum, M.D. have ACO affiliation data?

Abbe F. Rosenbaum, M.D. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Abbe F. Rosenbaum, M.D.?

Abbe F. Rosenbaum, M.D. is linked to CARDIOVASCULAR MEDICINE ASSOCIATES PA (billing NPI 1831123520) in the available physician profile data.

Does Abbe F. Rosenbaum, M.D. have Open Payments data?

Abbe F. Rosenbaum, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.